Diabetes & Endocrinology News

• Alert 'Twincretin' Tirzepatide Gets FDA Approval for Type 2 Diabetes Endocrinologists voice enthusiasm for the first approved agent for patients with type 2 diabetes that is a dual incretin agonist, but they also express concern about cost and patient accessibility.
  FDA Approvals, May 13, 2022
• Low-Calorie Ketogenic Diet Improves Immune Function In patients with obesity, a very-low-calorie ketogenic diet induces significant weight loss and has positive immunomodulatory properties, according to accumulating evidence.
  Medscape Medical News, May 13, 2022
• Are Physician White Coats Becoming Obsolete? The white coat has been the traditional physician garb. But since the pandemic, more have been wearing scrubs or more casual clothing. What's best for physicians to wear?
  Medscape Medical News, May 13, 2022
• Moderate Exercise Likely Curbs Kidney Decline in Sedentary Older Adults A structured moderate-intensity physical activity and strength/flexibility program slowed kidney function decline compared with health education, an analysis of a randomized clinical trial suggests.
  Reuters Health Information, May 12, 2022
• Alert FDA Approves Medtronic's Onyx Frontier Drug-Eluting Stent The low-profile stent shares the same platform as the previous generation Resolute Onyx zotarolimus-eluting stent and features an enhanced delivery system.
  FDA Approvals, May 13, 2022
• Diabetes Doubles Risk of Death From COVID-19; East-West Divide? 'These findings are interesting because they reveal that worse outcomes due to COVID-19 in people with diabetes can be reduced in the right setting,' says an expert.
  Medscape Medical News, May 13, 2022
• Hormonal Therapy Produces Best Cryptorchidism Outcomes Independent of surgery, hormonal therapy of young boys with cryptorchidism promotes testicular descent and increases the likelihood of adequate sperm quality when they are adults.
  First Look, May 13, 2022
• AACE 2022 First Fatty Liver Guidelines for Endocrinology, Primary Care Endocrinologists and primary care docs 'need to be the ones who are diagnosing and managing [non-alcoholic fatty liver disease] because there just aren't enough liver specialists to do that,' says author.
  Medscape Medical News, May 13, 2022
• Nearly 234,000 Cancer Cases Predicted in Canada This Year Although overall cancer rates are declining in Canada, the number of cases and deaths continue to climb due to population growth and an aging population.
  Medscape Medical News, May 13, 2022
• DDW 2022 NAFLD in Lean Patients Linked to CVD Risk The link between nonalcoholic fatty liver disease and higher risk of cardiovascular disease may extend beyond people who are overweight or living with obesity.
  Medscape Medical News, May 13, 2022
• Arkansas Sues Drugmakers, Pharmacy Benefit Managers Over Insulin Costs Arkansas's attorney general on Wednesday accused drugmakers and pharmacy benefit managers of colluding to drive up the price of insulin drugs, the latest in a series of lawsuits to take aim at skyrocketing insulin costs.
  Reuters Health Information, May 11, 2022
• Mixing BP Meds With NSAID May Be 'Triple Whammy' for Kidneys Combining a diuretic and renin-angiotensin system inhibitor with an NSAID like ibu-profen might raise the risk for kidney injury, a new analysis confirms, pointing to factors that might predict risk.
  Medscape Medical News, May 12, 2022
• ECO 2022 When Is the Ideal Time to Try for a Baby After Bariatric Surgery? European researchers assessed the weight of babies born to mothers after bariatric surgery and suggest an optimal time to conceive post-surgery.
  Medscape Medical News, May 12, 2022
• Early-Onset Colon Cancer Projected to Double by 2030 “We’re seeing a lot of younger people with this disease. It’s rather alarming,” says the author of a review that predicts further increases.
  Medscape Medical News, May 12, 2022
• Greater Triglyceride-Glucose Index Variability Tied to CV Risk Both the triglyceride-glucose index and its variability over several years predicted late risk for myocardial infarction or stroke in a prospective cohort study with more than 50,000 adults.
  First Look, May 12, 2022
• ESOC 2022 Exenatide Linked to Less Hyperglycemia After Stroke The diabetes drug may offer better control than insulin for hyperglycemia, a common condition following stroke that leads to worse outcomes.
  Medscape Medical News, May 11, 2022
• Espresso Coffee Associated With Increased Total Cholesterol New observational data show that drinking espresso coffee is linked to higher total cholesterol levels, particularly in men. Boiled or plunger coffee was tied to higher cholesterol in both men and women.
  Medscape Medical News, May 11, 2022
• Relugolix Combo Eases Long-Neglected Fibroid Symptom: Pain Combination therapy with relugolix (Orgovyx, Relumina), a gonadotropin-releasing hormone antagonist, significantly reduced the pain of uterine fibroids in a new study.
  Medscape Medical News, May 11, 2022
• Signs of Early Myocardial Injury Seen in Gestational Diabetes Speckle-tracking echo picked up early, asymptomatic signs of adverse ventricular remodeling in women with gestational diabetes that were not reliably detected by standard echocardiography.
  First Look, May 11, 2022
• In Canada, Poor Children With Type 1 Diabetes Less Likely to Receive an Insulin Pump Canadian children with type 1 diabetes who are poor are less likely to receive an insulin pump, especially where the cost is only partially funded, a new study finds.
  Reuters Health Information, May 09, 2022